Cargando…
THE TREATMENT OF COCCIDIOIDOMYCOSIS
Therapy of coccidioidomycosis continues to evolve. For primary pulmonary disease, antifungal therapy is frequently not required while prolonged courses of antifungals are generally needed for those in whom extrathoracic disseminated has occurred. Intravenous amphotericin B should be reserved for tho...
Autor principal: | AMPEL, Neil M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711193/ https://www.ncbi.nlm.nih.gov/pubmed/26465370 http://dx.doi.org/10.1590/S0036-46652015000700010 |
Ejemplares similares
-
The diagnosis of coccidioidomycosis
por: Ampel, Neil M
Publicado: (2010) -
Coccidioidomycosis: Changing Concepts and Knowledge Gaps
por: Ampel, Neil M.
Publicado: (2020) -
Central Nervous System Infections Due to Coccidioidomycosis
por: Jackson, Niki R., et al.
Publicado: (2019) -
Coccidioidomycosis in Patients Treated With Ruxolitinib
por: Kusne, Yael, et al.
Publicado: (2020) -
Impact of COVID-19 on diagnosis of primary pulmonary coccidioidomycosis
por: Ashcherkin, Nikita, et al.
Publicado: (2022)